Results 171 to 180 of about 398,369 (366)

Laxative Poisoning: Toxicological Analysis of Bisacodyl and Its Metabolite in Urine, Serum, and Stool

, 1998
Keiko Kudo, Chiaki Miyazaki, Ryo Kadoya, Tohru Imamura, Narumi Jitsufuchi, Noriaki Ikeda   +5 more
openalex   +1 more source

Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Over 20% of individuals with IBD were prescribed pain or sedative medications annually, with rising chronic and co‐prescribing rates. Risk factors included female sex, older age, Crohn's disease, and mental health conditions. Targeted interventions are needed to reduce harmful prescribing and promote safer alternatives.
Samantha Baillie, Sonia Saxena, Nishani Jayasooriya, Alex Bottle, Irene Petersen, Jonathan Blackwell, Richard Pollok   +6 more
wiley   +1 more source

Toxicology cart for stocking sufficient supplies of poisoning antidotes

, 1999
Herbert E. Pettit, Patrick E. McKinney, Louis E. Achusim, D. C. Lindsey   +3 more
openalex   +1 more source

Critical insights into the potential risks of antipsychotic drugs to fish, including through effects on behaviour

Biological Reviews, EarlyView.
ABSTRACT Antipsychotic drugs (APDs) are a diverse class of neuroactive pharmaceuticals increasingly detected in surface and ground waters globally. Some APDs are classified as posing a high environmental risk, due, in part, to their tendency to bioaccumulate in wildlife, including fish.
Gabrielle Wasser‐Bennett, A. Ross Brown, Samuel K. Maynard, Stewart F. Owen, Charles R. Tyler   +4 more
wiley   +1 more source

Toxicology or Effects of Poisons [PDF]

American Journal of Public Health, 1926
openaire   +2 more sources

Trends in novel opioid use and detections in exposures and police drug seizures in New South Wales

Drug and Alcohol Review, EarlyView.
Abstract Introduction Novel opioids, including non‐medical and non‐opium‐based opioids such as fentanyl analogues and nitazenes, pose a significant risk of harm due to their high potency. There is little published data on novel opioid detections and harms in Australia, yet they are implicated in multiple deaths.
Janette L. Smith, Jared Brown, David Atefi, Thanjira Jiranantakan, Vanessa Shaw, Christopher Ewers, Lorraine du Toit‐Prinsloo, Darren M. Roberts   +7 more
wiley   +1 more source

Prognostic value of cortisol and thyroid function tests in poisoned patients admitted to toxicology ICU [PDF]

, 2017
Shahin Shadnia, Nasim Zaman, Hossein Hassanian‐Moghaddam, Hamed Shafaroodi, Mina Padandar, Mohammad Hasan Rezaeizadeh   +5 more
openalex   +1 more source

Rehabilitation program for acute poisoning in a toxicological hospital

, 2021
Y. S. Goldfarb, A. V. Badalyan, Marina Yu. Marina, В. А. Щеткин, М. М. Potskhveriya   +4 more
openalex   +1 more source

A Scoping Review of the Emergence of Novel Synthetic Opioids in Australian Drug Markets: What Does This Mean for Harm Reduction Responses?

Drug and Alcohol Review, EarlyView.
ABSTRACT Issues Rising synthetic opioid deaths in North America, and the emergence of nitazene harms has driven concern about novel synthetic opioids (NSO) in Australia. This scoping review aimed to map what is known about NSOs in Australia. Approach Scoping review of peer‐reviewed and grey literature on NSO detections and harms.
Emmanuel Mammoliti, Suzanne Nielsen, Amanda Roxburgh   +2 more
wiley   +1 more source

Screening Procedure for Detection of Non-Steroidal Anti-inflammatory Drugs and their Metabolites in Urine as Part of a Systematic Toxicological Analysis Procedure for Acidic Drugs and Poisons by Gas Chromatography- Mass Spectrometry after Extractive Methylation*

, 2001
Hans H. Maurer, François X. Tauvel, Thomas Kræmer   +2 more
openalex   +1 more source